Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transitional Cell Tumor”

864 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 864 results

Early research (Phase 1)Study completedNCT00016237
What this trial is testing

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Bladder CancerKidney CancerLung Cancer
EMD Serono
Testing effectiveness (Phase 2)WithdrawnNCT05574504
What this trial is testing

Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy

Who this might be right for
Metastatic CancerUrothelial Carcinoma
AdventHealth
Testing effectiveness (Phase 2)Active Not RecruitingNCT03093922
What this trial is testing

Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

Who this might be right for
Urothelial CarcinomaLocally AdvancedUnresectable
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT02795156
What this trial is testing

Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

Who this might be right for
Non-small Cell Lung CarcinomaUrothelial CarcinomaGastrointestinal Carcinoma, Non-colon+1 more
SCRI Development Innovations, LLC 100
Testing effectiveness (Phase 2)Study completedNCT01687244
What this trial is testing

Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
FKD Therapies Oy 40
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Large-scale testing (Phase 3)Study completedNCT03410693
What this trial is testing

Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Carcinoma, Transitional Cell
Bayer 175
Very early researchNot Yet RecruitingNCT07671092
What this trial is testing

Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

Who this might be right for
Metastatic Urothelial CarcinomaBreast CancerTNBC - Triple-Negative Breast Cancer+2 more
RayzeBio, Inc. 40
Not applicableUnknownNCT03577132
What this trial is testing

The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer

Who this might be right for
Urothelial Carcinoma
Seoul National University Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06483334
What this trial is testing

Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)

Who this might be right for
Metastatic Urothelial CarcinomaLocally Advanced Urothelial Carcinoma
Merck Sharp & Dohme LLC 38
Large-scale testing (Phase 3)Study completedNCT02101931
What this trial is testing

A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine

Who this might be right for
Transitional Cell Carcinoma of the Bladder
Princess Al-Johara Al-Ibrahim Cancer Research Center 100
Not applicableStudy completedNCT03013894
What this trial is testing

Confocal Laser Endomicroscopy in the Lower Urinary Tract

Who this might be right for
Bladder NeoplasmUrothelial Carcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 73
Large-scale testing (Phase 3)Active Not RecruitingNCT04620239
What this trial is testing

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Who this might be right for
Transitional Cell Cancer of Renal Pelvis and Ureter
Steba Biotech S.A. 89
Not applicableLooking for participantsNCT07561957
What this trial is testing

A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines

Who this might be right for
Chronic Kidney DiseaseProteinuriaBlood Pressure Control+5 more
St. James's Hospital, Ireland 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04739800
What this trial is testing

Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

Who this might be right for
Fallopian Tube Mucinous AdenocarcinomaOvarian Seromucinous CarcinomaPlatinum-Refractory Fallopian Tube Carcinoma+47 more
National Cancer Institute (NCI) 120
Large-scale testing (Phase 3)Ended earlyNCT00191477
What this trial is testing

Instillation of Gemcitabine in Patients With Superficial Bladder Cancer

Who this might be right for
Bladder Neoplasms
Eli Lilly and Company 355
Not applicableEnrolling By InvitationNCT07091565
What this trial is testing

Supporting Sexual Recovery in Women With Bladder Cancer

Who this might be right for
Bladder CancerCystectomyFemale Sexual Dysfunction
King's College London 60
Testing effectiveness (Phase 2)Ended earlyNCT01042795
What this trial is testing

Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy

Who this might be right for
Urothelial CarcinomaBladder Cancer
University of Michigan 7
Early research (Phase 1)Active Not RecruitingNCT05768347
What this trial is testing

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Who this might be right for
Urothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 9
Testing effectiveness (Phase 2)Study completedNCT00173862
What this trial is testing

Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC

Who this might be right for
Transitional Cell Carcinoma
National Taiwan University Hospital 18
Next Page